Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Non-cash Items (2021 - 2025)

Century Therapeutics has reported Non-cash Items over the past 5 years, most recently at $6.1 million for Q4 2025.

  • Quarterly Non-cash Items fell 62.01% to $6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2025, down 62.01% year-over-year, with the annual reading at $6.1 million for FY2025, 62.01% down from the prior year.
  • Non-cash Items was $6.1 million for Q4 2025 at Century Therapeutics, down from $6.2 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $38.4 million in Q1 2023 and troughed at $227000.0 in Q4 2021.
  • The 5-year median for Non-cash Items is $6.1 million (2025), against an average of $10.5 million.
  • Year-over-year, Non-cash Items surged 1315.33% in 2022 and then tumbled 88.44% in 2024.
  • A 5-year view of Non-cash Items shows it stood at $227000.0 in 2021, then surged by 1315.33% to $3.2 million in 2022, then increased by 22.57% to $3.9 million in 2023, then soared by 309.98% to $16.1 million in 2024, then crashed by 62.01% to $6.1 million in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Non-cash Items are $6.1 million (Q4 2025), $6.2 million (Q3 2025), and $8.0 million (Q2 2025).